Načítá se...
Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells
Disease relapse remains a major factor limiting the survival of cancer patients. In the plasma cell malignancy multiple myeloma (MM), nearly all patients ultimately succumb to disease relapse and progression despite new therapies that have improved remission rates. Tumor regrowth indicates that clon...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Hematology
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3907757/ https://ncbi.nlm.nih.gov/pubmed/24345755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-08-524025 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|